Ledger.Open graph →
SEC Form D · filed August 1, 2017

Amplyx Pharmaceuticals, Inc

Offering
$66.7M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Harshjit Sethi · Frisco, TXDirectorNirmit Parikh · Frisco, TXDirectorMichael R. Ross · Salt Lake City, UTExec · DirectorJames Nieuwenhuys · London, United KingdomDirectorMicaela Kelley · London, United KingdomExec · DirectorJohan K?Rdel · San Diego, CADirectorFelix Shalit · Carmel, INExec · DirectorAndrew Skatoff · Santa Monica, CAExec · DirectorTed L. Hill · BOSTON, MADirectorChristian Schaffalitzky · London, United KingdomDirectorCRC Opportunistic Retail Fund I General Partner, LLC · Baltimore, MDDirectorVaibhav Agrawal · Frisco, TXDirectorManager of the General Partner CRC Opportunistic Retail Fund I GP Manager, LLC · Baltimore, MDDirectorIain Rawlinson · London, United KingdomDirectorTamerlan Abdikeev · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗